Imunon, Inc (IMNN)
NCM · Common · CUSIP 15117N602
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for IMNN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
15117N602 (prev. 15117N503 )
Market Cap
Micro Cap
Previous Symbol
CLSN (changed 9/21/2022)
Previous Name
Celsion Corp.
Business: Imunon, Inc is a clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body’s natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies.
Notes: May 30, 2017 -- Celsion Corporation (CLSN) will effect a one-for-fourteen (1-14) reverse split of its common stock. TCelsion Corporation (CLSN) will effect a one-for-fourteen (1-14) reverse split of its common stock. The CUSIP number will change to 15117N503.he CUSIP number will change to 15117N503._______________October 28, 2013 -- 1 for 4.5 reverse stock split and new cusip.

Company Contact

CEO
Stacy R. Lindborg
CFO
David Gaiero
Headquarters
997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648
Phone
609-896-9100
Fax
609-896-2200
Investor Relations
Jeff Church · 609-896-9100 · jchurch@celsion.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »